Q.Consult internet and find out how to make orally active protein pharmaceutical. What is the major problem to be encountered?

The biggest challenge in making an orally active protein pharmaceutical is that proteins are easily digested and broken down in the stomach and small intestine before they can be absorbed into the bloodstream.

The major problems you will encounter are:

• Digestion by stomach acid: The low pH of the stomach denatures (unfolds) the protein, destroying its three-dimensional shape and function.
• Enzymatic breakdown: Proteolytic enzymes in the stomach (pepsin) and the small intestine (trypsin, chymotrypsin) break the protein down into small peptides and amino acids.
• Poor absorption across the gut wall: Even if a protein survives digestion, it is a large, polar molecule that cannot easily cross the lipid-rich membranes of the intestinal lining into the blood. …

The idea of taking a protein drug as a pill — just like a common painkiller — is enormously appealing. For patients who need regular injections of medicines like insulin or growth hormone, an oral version would mean less pain, fewer infections, and far greater convenience. But turning that dream into reality runs into a fundamental biological barrier: the human digestive system is designed to destroy proteins.

Proteins are large, fragile molecules made of long chains of amino acids. When you eat a protein-rich meal, your stomach produces hydrochloric acid and an enzyme called pepsin that chop those chains into tiny fragments. The small intestine continues the job with trypsin, chymotrypsin, and other proteases. This is excellent for nutrition — your body needs those amino acids — but disastrous for a therapeutic protein, which must arrive intact at its target site. If you swallow insulin, for instance, it gets shredded into useless pieces before it ever reaches the bloodstream.

So the major problem is oral bioavailability — the fraction of the drug that survives digestion and crosses the intestinal wall into circulation. For most proteins, that fraction is essentially zero. The problem has two parts: first, the harsh chemical and enzymatic environment of the stomach and small intestine; second, the physical barrier of the intestinal lining itself. Even if a protein survives digestion, it is a large, water-soluble molecule that does not easily slip through the cells lining the gut.

How are researchers trying to solve this? Several strategies are being explored, and they often combine multiple approaches.

One approach is encapsulation — wrapping the protein in a protective shell. Tiny capsules made of polymers or lipids can shield the protein from stomach acid and enzymes. Some of these capsules are designed to dissolve only when they reach the higher pH of the small intestine, releasing the protein at a safer location. Others use materials that are themselves resistant to digestion, such as certain biodegradable polymers.

A second strategy is chemical modification of the protein itself. By attaching polyethylene glycol (PEG) chains — a process called PEGylation — the protein becomes larger and less recognisable to enzymes. This can slow down digestion and also help the protein stay in the bloodstream longer once absorbed. Another modification involves linking the protein to a molecule that helps it hitch a ride across the intestinal wall, such as vitamin B12 or a specific carrier peptide. …

Method — list the barriers, then the fix for each